Renal manifestations of systemic lupus erythematosus include several conditions secondary to systemic lupus erythematosus (SLE) effecting the kidneys. While lupus nephritis drives kidney damage in many patients other entities considered by some but not all separate, such as lupus podocytopathy, are also associated with SLE 1. Additionally, several systemic problems such as thromboembolic phenomenon or vasculitis may effects the kidneys in patients with SLE.
For a general overview and consideration of other system specific manifestations of SLE please refer to the article on systemic lupus erythematosus.
On this page:
Epidemiology
The vast majority of patients with SLE will develop will develop renal complications, and over half will develop lupus nephritis 2,3. While the percentage of patients who eventually progress to end-stage kidney disease may vary depending upon population, large studies indicate that around 4% will eventually progress to this outcome 3.
Pediatric patients with SLE appear to be particularly adversely effected in terms of renal outcomes 4.
Clinical presentation
Most patients with SLE will at some point in the disease progression have abnormal urine on laboratory examination, whether due to hematuria, casts, proteinuria or elevated creatinine ref. Lupus nephritis varies in severity, and patients may be asymptomatic, or present with acute kidney injury or chronic kidney disease 5.
Pathology
The pathogenesis of all the renal manifestations of SLE is not completely clear, however, the consensus is that genetics play a role, and more proximally immune complex deposition plays an import role 6. Glomerular lesions are typically present, and play a prominent role in various classification schema ref.
Radiographic features
While there are radiographic signs of the kidney damage of SLE such as renal atrophy (which will be apparent if present in almost any modality), assessment of the severity of renal disease as well as classification is typically done with urine analysis and histopathology if there has been a tissue biopsy.
Treatment and prognosis
Biopsy should be considered in patients with significantly abnormal urinary biomarkers not attributable to causes other than lupus nephritis, as the presence of nephritis should often change the treatment course. Immunosuppression is the mainstay of treatment for lupus nephritis 5.